Reduced capacity of tumour blood vessels to produce endothelium-derived relaxing factor: significance for blood flow modification
1996

Tumor Blood Flow and Nitric Oxide

Sample size: 10 publication Evidence: moderate

Author Information

Author(s): GM Tozer, VE Prise, KM Bell, MF Dennis, MRL Stratford, DJ Chaplin

Primary Institution: Tumour Microcirculation Group, Gray Laboratory Cancer Research Trust

Hypothesis

Tumor blood vessels have a reduced capacity to produce endothelium-derived relaxing factor (EDRF), affecting blood flow modification.

Conclusion

Tumor blood vessels can dilate in response to nitric oxide donors, but not to acetylcholine, indicating a defect in EDRF production.

Supporting Evidence

  • Sodium nitroprusside (SNP) and NOC-7 effectively dilated tumor blood vessels.
  • Acetylcholine (ACh) caused vasoconstriction in tumors, unlike in normal tissues.
  • Nitrite levels significantly increased in tumor effluent after SNP administration.
  • Vascular resistance was significantly different at various doses of SNP and ACh.

Takeaway

This study found that while some drugs can help blood flow in tumors, others don't work because tumors can't release a special chemical that helps blood vessels relax.

Methodology

Isolated rat P22 tumor and normal hindlimb preparations were perfused ex vivo to measure vascular resistance after administering various vasodilators.

Limitations

The study only used a specific type of tumor and may not represent all tumor types.

Participant Demographics

10 to 11-week-old male BD9 rats were used for the experiments.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.01

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication